Dark Forest Capital Management’s Cytokinetics CYTK Stock Holding History

Dark Forest Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Buy	+16,914	New	+$1.07M	0.1%	336
2024 Q2	–	Sell	-14,437	Closed	-$1.01M	–	703
2024 Q1	$1.01M	Buy	+14,437	New	+$1.12M	0.17%	115
2023 Q3	–	Sell	-21,546	Closed	-$703K	–	1123
2023 Q2	$703K	Buy	21,546 +14,619	+211%	+$541K	0.06%	472
2023 Q1	$244K	Buy	+6,927	New	+$283K	0.06%	308
2021 Q4	–	Sell	-193	Closed	-$7K	–	1505
2021 Q3	$7K	Sell	193 -16	-8%	-$471	﹤0.01%	1040
2021 Q2	$4K	Buy	+209	New	+$4.91K	﹤0.01%	707

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dark Forest Capital Management's CYTK Position: Q1 2026 in Review

Dark Forest Capital Management opened a new position in Cytokinetics (CYTK) in Q1 2026: 16,914 shares worth $1.11M. The stake represents 0.1% of the portfolio and ranks #336 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in CYTK as recently as Q1 2024.

Dark Forest Capital Management first reported a position in CYTK in Q2 2021 and has held it in 6 quarters since. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

Dark Forest Capital Management held 16,914 shares of Cytokinetics worth $1.11M as of Q1 2026.
Cytokinetics was a new Dark Forest Capital Management position in Q1 2026.
Cytokinetics made up 0.1% of Dark Forest Capital Management's portfolio in Q1 2026, its #336 holding.
Dark Forest Capital Management first reported a position in Cytokinetics in Q2 2021 and has held it in 6 quarters since.
439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.